Drugmaker Supernus Pharmaceuticals said on Monday it will acquire Sage Therapeutics , which makes treatments for neurological conditions, in a deal worth up to $795 million.

Strengthens Supernus’ leading presence in neuropsychiatric conditions with an innovative commercial product, ZURZUVAE ® (zuranolone), and a novel CNS discovery platform. Expected to be significantly ...

Critical Metals Corp has received a letter of interest from the U.S. Export-Import Bank (EXIM) for a loan worth up to $120 ...

The UK Government has partnered with global technology giants to provide artificial intelligence training to 7.5 million ...

How an Ovid-quoting London broadsheet from the late seventeenth century spawned “Dear Abby,” Dan Savage, and Reddit’s Am I ...

Covid cases continue to rise steadily in the UK, fuelling concerns of a summer wave, new figures indicate. The latest figures ...

According to the Aiken County Sheriff’s Office, a fuel truck, traveling eastbound on I-20, was involved in a fiery crash early Saturday.

A New Sugoroku Game Featuring the Beloved Character Crayon Shinchan is Now Accepting Pre-Registrations The game follows Shinchan and his fr ...

Android Auto 14.6 stable & beta release available for download with stability improvements and bug fixes. Upcoming features ...

Peoria No Ban No Wall and River City Rainbow Collective were among several local organizations hosting a peaceful rally after ...